환자들이 선호하는 발톱진균증의 경구 치료법
Preferred Oral Antifungal Treatment in Toenail Onychomycosis Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Treatment of toenail onychomycosis requires long term oral medication of antifungal agent. So many factors such as preferred treatment option can affect the compliance and cure rate. Objectives: The objective of the present study was to identify most preferred treatment options for toenail onychomycosis patients. Methods: This study was undertaken on 190 patients treated toenail onychomycosis, who visited Hanyang University Guri hospital, Konkuk University hospital and Asan Medical center during the period between March 2008 to April 2008. Results: 1. Mean age of patients was 53.5±15.5 years old, 108 patients (56.8%) were female and 82 patients (43.2%) were male. 2. Mean duration of disease was 7 years 11 months (7.9±8.8 years). 3. The motives of treatment for toenail onychomycosis were 'ugly appearance' (39.8%) and 'pruritus' (33.9%). 4. Seventy six percent of patients had history of treatment for toenail onychomycosis. Most of them (43%) visited dermatologist's office and 14% of them used folk remedy. 5. Continuous therapy was the most common method (47%) in previous treatment. And it was the most common treatment option irrespective of age, disease duration and gender. 6. The most preferred treatment option was also continuous therapy (57%). And 69% of patients who received continuous therapy preferred it, but it was only 48% in pulse therapy group and 38% in weekly pulse therapy group. 7. Sixty six percent of the toenail onychomycosis patients had associated disease. Conclusions: Continuous therapy was the most convenient method for toenail onychomycosis patients who visited general hospital.
Abstract
Background: Treatment of toenail onychomycosis requires long term oral medication of antifungal agent. So many factors such as preferred treatment option can affect the compliance and cure rate. Objectives: The objective of the present study was to identify most preferred treatment options for toenail onychomycosis patients. Methods: This study was undertaken on 190 patients treated toenail onychomycosis, who visited Hanyang University Guri hospital, Konkuk University hospital and Asan Medical center during the period between March 2008 to April 2008. Results: 1. Mean age of patients was 53.5±15.5 years old, 108 patients (56.8%) were female and 82 patients (43.2%) were male. 2. Mean duration of disease was 7 years 11 months (7.9±8.8 years). 3. The motives of treatment for toenail onychomycosis were 'ugly appearance' (39.8%) and 'pruritus' (33.9%). 4. Seventy six percent of patients had history of treatment for toenail onychomycosis. Most of them (43%) visited dermatologist's office and 14% of them used folk remedy. 5. Continuous therapy was the most common method (47%) in previous treatment. And it was the most common treatment option irrespective of age, disease duration and gender. 6. The most preferred treatment option was also continuous therapy (57%). And 69% of patients who received continuous therapy preferred it, but it was only 48% in pulse therapy group and 38% in weekly pulse therapy group. 7. Sixty six percent of the toenail onychomycosis patients had associated disease. Conclusions: Continuous therapy was the most convenient method for toenail onychomycosis patients who visited general hospital.
참고문헌 (18)
- Szepietowski JC, "Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: A survey of 2761 patients", Arch Dermatol, 142, pp.1279~1284 (2006)
- 강명승, "발톱진균증의 침범 정도에 따른 완치율과 정상화까지의 기간 및 재발률", 대한의진균학회지, 13(2), pp.53~60 (2008), 대한의진균학회1
- 이양원, "족부 조갑진균증 치료에서 수종 경구용 항진균제에 따른 환자 순응도에 대한 후향적 연구", 대한의진균학회지, 7(3), pp.149~154 (2002), 대한의진균학회1
- Robert DT., "Prevalence of dermatophyte onychomycosis in the United Kingdom: result of an omnibus survey", Br J Dermatol, 126, pp.23~27 (1992)
- Heikkila H, "The prevalence of onychomycosis in Finland", Br J Dermatol, 133, pp.699~703 (1995)
- Sais G, "Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study", Br J Dermatol, 132, pp.758~761 (1995)
- Roberts DT., "Oral therapeutic agents in fungal nail disease", J Am Acad Dermatol, 31, pp.78~81 (1994)
- Gupta AK, "Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey", Br J Dermatol, 139, pp.665~671 (1998)
- Sohn JK, "Onychomycosis in the Elderly", Kor J Med Mycol, 6, pp.77~83 (2001)
- 송영찬, "조갑진균증 환자의 동반질환 및 병용 약물에 관한 연구", 대한의진균학회지, 12(3), pp.163~172 (2007), 대한의진균학회1
- Goodfield MJD, "Short term treatment of dermatophyte onychomycosis with terbinafine", Br Med J, 304, pp.115~124 (1992)
- Haneke E, "Safety and efficacy of intermittent therapy with itraconazole in finger and toenail onychomycosis: a multicentre trial", Mycoses, 41, pp.521~527 (1998)
- Evans EGV, "Double-blind, randomized study of continuous terbinafine compared with intermittent itraconazole in the treatment of toenail onychomycosis", Br Med J, 318, pp.1031~1035 (1999)
- Heikkila H, "Long-term results of patients with onychomycosis treated with itraconazole", Acta Dermatol Venereol, 77, pp.70~71 (1997)
- Baran R, "A randomized trial of amorolfine 5% nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region", Br J Dermatol, 142, pp.1177~1183 (2000)
- Havu V, "A double blind, randomized study to compare the efficacy and safety of terbinafine with fluconazole in the treatment of onychomycosis", Br J Dermatol, 142, pp.97~102 (2000)
- 이양원, "조갑진균증의 치료와 환자 순응도에 대한 고찰", 대한의진균학회지, 10(3), pp.83~90 (2005), 대한의진균학회1
- 김지은, "조갑진균증 치료의 순응도와 장기적 추적 관찰", 대한의진균학회지, 8(3), pp.110~117 (2003), 대한의진균학회1